Max Robotics — Global Service Robot Directory + US Certification

About

Daniel Reim is a surgical oncologist whose research has substantially advanced the understanding and practice of minimally invasive surgery for gastric cancer. His work centers on comparative outcomes between robotic, laparoscopic, and open gastrectomy, with a particular focus on oncological safety, lymph node dissection quality, and patient recovery. Reim's most influential contribution — a propensity score-matched study comparing all three surgical approaches (2017, 100 citations) — provided rigorous evidence that robotic and laparoscopic techniques can achieve outcomes comparable to open surgery while offering potential perioperative advantages. His earlier analysis of 200 consecutive robotic gastrectomies (2013) was among the first to demonstrate that surgical experience with robotic systems translates into measurably improved outcomes, lending credibility to the technology's adoption curve. Notably, Reim played a founding role in IMIGASTRIC, an international multi-institutional consortium designed to generate large-scale, high-quality data on minimally invasive gastric cancer surgery — a landmark collaborative effort reflected in multiple publications. His 2015 literature review critically evaluating study limitations in the field further underscores his commitment to methodological rigor. With over 290 citations across his key publications, Reim's body of work has meaningfully shaped surgical decision-making for gastric cancer worldwide.